320 filings
Page 4 of 16
8-K
9ln07a4cz vw
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am
424B5
wtdbjt
28 Sep 21
Prospectus supplement for primary offering
8:30am
8-K
v05sb21f6tu8
15 Sep 21
Departure of Directors or Certain Officers
12:00am
EFFECT
o6y23l i8
10 Aug 21
Notice of effectiveness
12:15am
424B3
3sk0t66ytqeb y36
5 Aug 21
Prospectus supplement
9:43pm
CORRESP
2qq gsfbfg3ixn
5 Aug 21
Correspondence with SEC
12:00am
UPLOAD
8b7 kwcj99ysk
4 Aug 21
Letter from SEC
12:00am
S-3
wzhseh3sqk1rv63ap
29 Jul 21
Shelf registration
12:00am
8-K
m8ikf3lpa5q2w vogb
26 Jul 21
Skye Bioscience Appoints Biotech Executive
12:40pm
8-K
g7ad0kmf
22 Jul 21
Entry into a Material Definitive Agreement
8:00am
424B3
vtqtngc
7 May 21
Prospectus supplement
8:03am
424B3
1zsao8qwhohv3rd3y2
2 Mar 21
Prospectus supplement
12:00am
8-K
h436y
3 Feb 21
Submission of Matters to a Vote of Security Holders
5:16pm
8-K
d30ksm1 6s7wu
19 Jan 21
Amendments to Articles of Incorporation or Bylaws
10:57am
PRE 14A
1lg 60wq8k1ogt4
11 Dec 20
Preliminary proxy
5:30pm
424B3
n04kwxh6up0
9 Nov 20
Prospectus supplement
12:00am